Lord Jim O’Neill
AMR advisor calls for public utility company to tackle AMR
March 28, 2019Medical Communications, Research and Development AMR, Lord Jim O'Neill, antimicrobial resistance, pharma, public health
Lord Jim O’Neill, an economist and former government advisor on antimicrobial resistance (AMR), has accused the pharmaceutical industry of “spewing …
Urgent action needed on antimicrobial resistance, says government report
May 19, 2016Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance
A new UK governmental report has warned that the global rise of antimicrobial resistance is set to worsen, with the …
Pharma leads global call for action on antimicrobial resistance
January 21, 2016Manufacturing and Production, Research and Development Davos, Lord Jim O'Neill, Review on antimicrobial resistance, World Economic Forum, antibiotic resistance, antimicrobial resistance
More than 70 leading international pharmaceutical and biotechnology companies, as well as industry associations, have come together to call for …
Latest content
New CCO Ogburn joins Cori Clinical
October 21, 2026
Claris reports visual acuity gains with experimental LSCD treatment
October 21, 2026
Amphista doses first patient in AML trial of protein degrader
October 20, 2026
Jennings becomes President of Beckman Coulter Diagnostics
October 19, 2026
